Hepatoprotective Effect of Royal Jelly Against Cisplatin-Induced Biochemical, Oxidative Stress, Anti-Oxidants And Histopathological Abnormalities by Abdelhafiz, Hanan  Abdelhamid et al.
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.27, 2014 
 
28 
Hepatoprotective Effect of Royal Jelly Against Cisplatin-Induced 
Biochemical, Oxidative Stress, Anti-Oxidants And 
Histopathological Abnormalities 
Hanan  Abdelhamid Abdelhafiz1, Attalla Farag El-kott 2,3* and Mohamed Rabea Elesh1 
1. Biochemistry Dept., Faculty Of Science, Beni-Suef University, Egypt 
2. Deanship Of Scientific Reseaech, King Khalid University, KSA 
3. Zoology Dept., Faculty Of Science, Damanhour University, Egypt 
* E-mail of the corresponding author: elkottaf@yahoo.com, elkottaf@kku.edu.sa 
Abstract 
The study aimed to evaluate the changes of liver functions, oxidative stress, anti-oxidants and 
histopathological investigations in Cisplatin-induced hepatotoxicity and the royal jelly ameliorative effects. The 
forty male mice were divided into 4 groups. The first group was control, Group II: animals were received royal 
jelly (150 mg/kg), Group III: animals were received cisplatin (3.5 mg/kg body weight of Cisplatin once every 2 
days), group IV: animals were received the royal jelly + Cisplatin, for 10 days. At the end of experiment Blood 
was collected and analyzed for blood alanine aminotransferase (ALT), aspartate aminotransferase (AST), 
Albumin. The Liver samples were stored for the measurement of malondialdehyde (MDA), total antioxidant and 
catalase (CAT) activities and another hepatic tissues were processed for histopathology. Cisplatin given to mice 
induced a marked hepatic injuries, characterized with a significant increase in serum ALT, AST and MDA and 
lower albumin, total antioxidant, and CAT activities. In the groups that were administered royal jelly in 
association with cisplatin, improvement was observed in oxidative stress parameter (MDA), other hepatic 
biochemical parameters, and histopathological examinations with royal jelly being more effective. The results 
obtained suggested that royal jelly significantly attenuated the cisplatin-hepatotoxicity, because it act as free 
radical scavenger and lipid peroxidation inhibitor.  
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1. Introduction 
Drugs Cytotoxic used in chemotherapy cause side-effects for normal cells in addition to the devastation 
and prevention of proliferation of cancer cells (Mihelic, 2005). In addition to its therapeutic  effects, also 
chemotherapy produces pain, vomiting, nausea, anorexia, alopecia, cachexia, mucositis, depression, impaired 
taste, dehydration, and anxiety (Coates et al., 1983; Giordano & Jatoi, 2005). These side-effects are mostly 
temporary and are preventable or can be minimized with appropriate treatment and care (Coates et al., 1983). 
Lack of suitability rule of side-effects causes patients to give up the chemotherapy (Mollaoğlu & Erdoğan, 
2014). 
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Cisplatin is a platinum-coordinated complex-based anticancer chemotherapy drug used against several 
human cancers (Adams, 1996). Despite the fact of its effective anti-cancer action, it  exerts many unwanted 
adverse effects including hepatotoxicity, ototoxicity, nephrotoxicity, spermiotoxicity myelo-suppression,  and  
emetogenesis  (Hassan, Chibber, & Naseem, 2010). The renal toxicity of cisplatin has been known but little is 
known about Cisplatin-induced liver injury. Hepatic toxicity is not considered as a dose limiting toxicity for 
cisplatin, but hepatic toxicity can occur when the anti-cancer drug is administered at high doses (Zicca et al., 
2002). Some studies have reported the importance of oxidative stress in cisplatin-induced toxicity including liver 
(Yousef, Saad, & El-Shennawy, 2009).  Studies  have  suggested that oxidative stress might be generated in the 
pathogenesis of Cisplatin-induced toxicity (Mansour, Hafez, & Fahmy, 2006). The free radicals especially 
oxygen species (OS) have been suggested as a causative agent for death of the cell in many different 
pathological phases and in different models of toxic liver failure including cisplatin (Ahmed, Omar, Ragb, & 
Nasser, 2011). 
Several natural products occurring antioxidants influence the antioxidant enzymes and provide 
protection against oxidative stress for free radical-induced cell damage, thereby causing hepatic diseases 
(Waseem, Pandey, Tomar, Raisuddin, & Parvez, 2014). Royal Jelly (RJ) is a secretion of mandibular and 
hypopharyngeal glands of Honey bees workers. Royal jelly is used to feed temporarily the brood of workers and 
drones but it is a unique food of the bee queen for both her larval and adult life span. Royal jelly for years has 
been widely used in Asia and Europe as healthy food, folkish cosmetic or medical product to promote longevity. 
It has been manifested to have many pharmaceutical activities such as: antimicrobial, disinfectant action, anti-
hypercholesterolemic, antioxidant, anti-inflammatory, anti-hyperglycemic and anti-tumor activity that may be 
responsible for assisting the health welfare through aging. Royal jelly (RJ)  also  has  hepatoprotective effects 
(Kanbur et al., 2009) and anti-oxidant (El-Nekeety et al., 2007). Royal jelly has been designed to contain the 
glycoprotein (57-kDa) which is considered to stimulate hepatic tissues regeneration and hepatocyte development 
(Zimmermann, 2002). The present study was done to assess the effects of administration of royal jelly in mice 
with cisplatin-induced hepatic toxicity. 
2. Materials and Methods 
2.1. Experimental animals 
Forty healthy adult male Swiss albino mice, weighing 25.0 ± 2.0 g, 50 – 60 days old, were obtained 
from the animal house of the National Cancer Institute (NCI), Cairo University, Egypt. The animals were kept 
under standard environmental conditions on 12 hours light/dark cycle under a constant temperature of (25+1) 0C 
, and a relative 50–60% humidity. Free access to water and food was allowed at experimental period. Mice were 
acclimatized to conditions of laboratory for one week prior to experiments. Mice were housed five/cage in the 
sterilized plastic cages. 
2.2. Experimental design 
The forty mice were randomized and divided into four groups as follows: 
Group I: Control group was injected once every 2 days from day 1 to 10 with 0.2 mL saline solution 
intraperitoneally. 
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Group II: Royal jelly group was given orally once daily at royal jelly doses at 150 mg/kg (Inoue et al., 2008).  
Group III: Cisplatin mice group was injected intraperitoneally by 3.5 mg/kg body weight with cisplatin once 
every 2 days (Liao et al., 2008).  
Group IV: Royal jelly + Cisplatin mice group was given orally once daily at royal jelly doses of 150 mg/kg for 
10 consecutive days from day 1 to 10, then 3.5 mg/kg body weight of Cisplatin was inoculated intraperitoneally 
once every 2 days in the same period. 
2.3. Chemicals (Reagents) 
 All reagents used in this study were analytical of the purest grades. All glasses and plastic wares were 
washed with acid and detergent, and washed with distilled water. 
2.3.1. Cisplatin  
Cis-platinum (II)-diammine dichloride (CIS, lot. No. 1028, batch #3400956225392, Mylan, Germany) 1 
mg/ml was obtained from Oncotec pharma production GmbH Am pharmapark 06861 Dessau-RoBlau-Germany. 
2.3.2 Royal Jelly 
Soft Gelatinous Capsules (1000 mg/Capsule) was obtained from pharco pharmaceuticals Company, 
Alexandria-Egypt, and kept at temperature not exceeding 30°C until use. Each capsule contains lyophilized 
Royal Jelly (6%) 10-HAD 340 mg (equivalent to 1000 mg Crude Royal Jelly). 150 mg/kg RJ aliquots were 
dissolved in distilled water and administered orally for 10 consecutive days to groups of royal jelly, 
Cisplatin+Royal jelly mice. 
5- Weight 
Animal weight was calculated and evaluated at the first day of Cisplatin administration and the final 
day of the experiment. 
2.4. Dissection of animals    
At the end of the study, the animals were fasted overnight and maintained under light ether anesthesia, 
sacrificed by cervical dislocation, and samples were collected from each animal into tubes both with and without 
anticoagulants. The liver dissected out, part of the liver tissue was transferred into 10% buffered formalin for 
histopathology, and the another part of hepatic tissue was used for the analysis of antioxidant and oxidative 
stress markers. 
2.5 Blood and tissue samples collection 
Blood was drawn from all 10 animals in each group and centrifuged at 3000 rpm for 10 minutes. 
Plasma and Serum samples were stored at 0°C until biochemical analysis liver functions (AST, ALT and 
Albumin). Liver was removed, cleared from adhering connective tissue; and homogenized for 10 sec in a 
Polytron,  after being mixed with phosphate buffer, pH 7.0, in an ice-containing medium. The homogenates were 
centrifuged at 19,000 rpm at 4°C for 30 min and the supernatants obtained were transferred into eppendorf tubes, 
and preserved at -80°C in a deep freezer until used for lipid peroxidation Malondialdehyde (MDA) and anti-
oxidant enzymes (Total antioxidants and catalase) analysis (Maldonado et al., 2003). The another part of liver 
was fixed in 10% formalin for histopathological examination (Barrera et al., 2003). 
2.6 Statistical Analysis 
The data were analyzed using one-way analysis of variance (ANOVA) followed by LSD computers to compare 
various groups. Results were expressed as main±SD.  
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3. The results 
3.1.Toxicity symptoms 
The Cisplatin toxicity symptoms were observed on the first day showed slight toxic symptoms. These 
include inactiveness, loss of appetite, slow movement, all these lead to decrease in the body weight. After the 
cisplatin administration, variety of clinical signs were observed such as decrease food and water intake, diaries 
nerves, brittleness of skin hair and, after that highly decrease in body weight, the highly significant difference in 
body weight was observed between different groups when compared with control group as shown in table 1. 
Table (1): The animal weight changes in different experimental animals 
 
 
 
 
The data were expressed as Mean+SD, * = P<0.05 
3.2. Biochemical investigations 
Liver functions there were differences in the hepatic enzyme activities among the different treatment 
groups. The ALT, AST and the albumin (ALB) concentrations were significant increasing in Cisplatin mice 
group except RJ and control groups as shown table (2). 
Table 2:  the liver functions in different experimental animals 
  
 
 
 
 
The data were expressed as Mean+SD, * = P<0.05 and ** = P<0.001 
3.3. The antioxidants and oxidative stress observations 
In the table (3), the total antioxidants were highly significant decreasing in CP and cisplatin treated with 
RJ groups, but the animals injected with RJ were no differences when compared with control one. The catalase 
was highly significant decreasing in CP, but the catalase was highly significant increasing in RJ group when 
compared with control group. The MDA was highly significant increasing in CP and RJ injected by CP group, 
there was a slightly increasing when compared with control group. While the MDA was highly significant 
decreasing in RJ group. 
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Table (3): The antioxidants and oxidative stress in different experimental animals 
 
 
 
 
 
 
 
 
 
 
The data were expressed as Mean+SD, * = P<0.05 and ** = P<0.001 
 
3.4. Histopathological  observations. 
There were no histological observations differences between mice administrated with Royal jelly group 
and control ones which received no any treated. The hepatic cells or hepatocytes are polyhedral in shape with a 
relatively large sizes and a noticeable granular cytoplasm. Each cell is embodying a prominent centrally located 
nucleus with one or two nucleoli in addition to a number of chromatin particles (Fig. 1A & 1B).   
Microscopic examination of liver sections taken from mice of cisplatin mice group showed different 
signs of injury in the hepatocytes where most of them were hypertrophied and possessed faintly stained and 
vacuolated cytoplasm. In addition, groups of necrotic hepatocytes could be seen in different areas of the liver 
tissue. binucleated  hepatocytes were more frequent as compared with the  control and some degenerated 
binucleate cells were observed with faint eosinophilic cytoplasm and chromatolytic nuclei. Cisplatin appeared to 
have different effects on the nuclei of hepatocytes, where some nuclei were swollen with clumped chromatin at 
their periphery. Few hepatocytes appeared to have nuclei with signs of karyorrhexis. Severe damages were 
observed in the liver architecture; the normal arrangement of the hepatocytes wasn't easily recognized and some 
hepatic strands were dissociated. This is probably due to dilatation of the central veins and hepatic sinusoids. 
Particularly, leucocytic inflammatory cells were observed all over the liver tissue (Fig. 1C). 
Microscopic examination of the liver sections taken from mice i.p injection of cisplatin and treated with 
royal jelly showed the hepatocytes were little severe effects of cisplatin on the hepatic tissues than observed in 
other cases injected with cisplatin only (Fig.1D). 
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Figure (1): Histological sections of control and royal jelly mice groups: the tissues were organized into 
lobules which are roughly hexagonal in shape, with a central vein (CV) in the middle. Within each 
lobule, hepatocytes are arranged into hepatic cords running radiantly from the central vein and are 
separated by adjacent sinusoids. Hepatic sections of cisplatin injected mice group: showing a 
sinusoid blood congestion (*). Accumulation of mononuclear cells inflammatory cells (IC), 
binucleated hepatic cells and vacuoles (V) were present. Hepatic sections of cisplatin injected mice 
treated with royal jelly: showing normal architectural except accumulation of Inflammatory cells 
(IC) and dilated blood sinusoids (DS). 
4. Discussion  
At the beginning of last century, the only treatment available for patients with solid tumors was surgery, 
associated with high morbidity and mortality. Over the past 40 years, chemotherapy resulted in a progressive 
improvement in survival rates of patients with malignant neoplasm. Chemotherapy is one of the most widely 
used interventions for treatment of cancer (Klareskog et al., 2004). 
Cisplatin is one of the most potent anticancer drugs used in chemotherapy (Van Basten et al., 1997). 
Also, Cisplatin  is a kind of platinum coordinated complex-based anti-cancer drug, which is widely used in anti-
cancer chemotherapy, including oral, lung, metastatic  tumors  of  head, testis,  ovaries and neck cancer,  
advanced bladder cancer, and many other solid tumors (Kumar et al., 2014). 
In spite of its significant anti-cancer activity, the clinical use of cisplatin is often limited by its 
undesirable side effects such as nephrotoxicity (Madias & Harrington, 1978). Hepatic toxicity can also happen 
when cisplatin is administered at high doses (Cersosimo, 1993). The liver is known to accumulate significant 
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amounts of CP, second only to the kidney (El-Sayyad et al., 2009); thus hepatic toxicity can be related with 
cisplatin treatment (Liao et al., 2008).  
Recent studies suggest that using plant-derived chemo-preventive agents in combination with 
chemotherapy can enhance the efficacy of chemotherapeutic agents and lower their toxicity to normal tissues 
(Ma et al., 2014; Silici, Ekmekcioglu, Kanbur, & Deniz, 2011). This study investigates the effects of royal jelly 
on cisplatin-induced liver damages. Animals that received cisplatin showed severe biochemical and histological 
changes. On the other hand, treatment with royal jelly caused a significant improvement in tested parameters, 
which were significantly altered by cisplatin administration. Among biochemical parameters, the increase in 
AST and ALT activities in the cisplatin mice group was found to be related to damage in the liver and change in 
liver functions. The elevation in levels of serum AST and ALT has been attributed to the damaged structural 
integrity of the liver, because these enzymes are normally found in the cytoplasm and are released into the 
circulation after hepatic damage (Sallie, Michael Tredger, & Williams, 1991). Mora et al. (Mora, Antunes, 
Francescato, & Bianchi, 2003) have also described the increasing effects of cisplatin on changes in serum AST 
and ALT activities and decrease of albumin level. On the other hand, treatment with the royal jelly remarkably 
inhibited cisplatin-induced liver damage as evidenced by decreased serum activities of AST and ALT and 
increase of albumin level. Similar results were obtained by Uzbekova et al., (Uzbekova, Chugunova, Makarova, 
Ryabkov, & Mirgorodskaya, 1998) and these researchers have reported royal jelly may protect the liver from 
damage because serum parameters such as AST, ALT, and albumin content have shown a pronounced tendency 
to normalizationon thyroxin-induced liver damage (Uzbekova et al., 1998). In the present study, the royal jelly 
significantly restores the changes of ALT, AST and albumin due to its antioxidant effect and its ability to act as a 
free radical scavenger in case the cisplatin hepatotoxicity, thereby protecting membrane permeability (Ashry & 
Elkady, 2014). 
Cisplatin increases lipid peroxidation in the treated tissue of mice. The drug is also involved in altering 
the thiol status of the tissue with concomitant alterations in the enzymatic antioxidants (Kunworarath, Muangnil, 
Itharat, & Hiranyachattada, 2014). In the present study, total antioxidants and catalase levels were significantly 
decreased after cisplatin therapy. This effect may be a secondary event following the cisplatin-induced increase 
in free radical generation and/or decrease in lipid peroxidation protecting enzymes. Cisplatin can cause the 
generation of oxygen free radicals , such as superoxide, hydrogen peroxide anions and hydroxyl radicals. The 
hydroxyl radical is capable of abstracting a hydrogen atom from polyunsaturated fatty acids in membrane lipids 
to initiate lipid peroxidation. These radicals can evoke extensive cell damage, reacting with proteins, membrane 
lipids, and nucleic acids (Emerit, Beaumont, & Trivin, 2001). Moreover, depletion of glutathione and catalase 
may contribute to CP-induced lipid peroxidation (GREGGI ANTUNES, D'ARC C DARIN, & BIANCHI, 2000). 
Thus, an alteration in enzymatic antioxidant status with increase in lipid peroxidation and nitric oxide indicates 
that the enzymes play an important role in combating free radical induced oxidative stress on the tissue. This 
speculation agreed with previous studies which have demonstrated the involvement of lipid peroxidation, 
oxidative stress, and mitochondria dysfunction in cisplatin-induced liver toxicity (Yilmaz et al., 2005).  
The present study showed many histopathological and biochemical abnormalities in the liver of 
cisplatin-injected animals with single dose, which is inconsistent with the previous results (El-Sayyad et al., 
2009; Kart, Cigremis, Karaman, & Ozen, 2010). Moreover, the treatment with RJ ameliorated CP-induced liver 
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damages associated with free radical  production    by  enhancing the enzyme activity to normal values and 
preserving the liver parenchyma; where the appearance of the hepatic cells, Von Kupffer cells, sinusoids and the 
portal triad was similar to the control rats; these results are inconsistent with the previous studies (Dorababu, 
Joshi, Kumar, Chaturvedi, & Goel, 2006; Kupradinun et al., 2011). 
El-Sayyad et al. (El-Sayyad et al., 2009) reported that light microscopic observations  revealed  that  
cisplatin  caused  hepatic toxicity, including disintegration of hepatic cords, necrotic tissues and focal 
inflammation, peri-portal fibrosis and increased apoptosis. It is well known that cisplatin induces oxidative stress 
(Srivastava et al., 1996).  
In the present study, compared  with  groups  royal jelly, cisplatin and cisplatin treated with royal jelly 
groups with control mice, the histopathological abnormalities in liver tissues were becoming less prominent, 
which referred to inflammatory infiltration, periportal extravasation, marked disruption of hepatic cords  and  
dilated blood sinusoids in cisplatin mice group. Moreover, the histological analysis revealed that mice cisplatin 
injected and treated with royal jelly led to reduced hepatotoxicity  in both experimental animal models. Most 
likely, the reduction of the hepatic tissue alteration observed for RJ-CP- treated mice is due to the ability of 
liposomes to modify the bio-distribution of the entrapped drug (de Carvalho Maroni et al., 2012).  
Conclusion: The results obtained suggested that royal jelly significantly attenuated the hepatotoxicity 
caused by cisplatin. The protective effect of royal jelly is associated with its anti-oxidant properties because it act 
as lipid peroxidation inhibitor and free radical scavenger. The cisplatin-induced changes in histopathologic 
findings of liver were partially reversed by treatment with royal jelly.  
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